Ethyl Ether (Ether)

Subscribe to Selected New Research on Ethyl Ether

1834 relevant articles (44 outcomes, 121 trials/studies) found for this Bio-Agent

Description: A mobile, very volatile, highly flammable liquid used as an inhalation anesthetic and as a solvent for waxes, fats, oils, perfumes, alkaloids, and gums. It is mildly irritating to skin and mucous membranes.

Also Known As:

Ether; Diethyl Ether; Ether, Ethyl; Ether, Diethyl; Ethane, 1,1'-oxybis-

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 42

Ethers: 143

Ethyl Ethers: 2

Ethyl Ether: 1834

lymph node revealing solution: 8

analgesin: 1

bis(2-chloroethyl)ether: 1

Experts

1.	Beadle, James R: 4 articles (09/2004 - 01/2004)
2.	Hostetler, Karl Y: 4 articles (09/2004 - 01/2004)
3.	Wan, W Brad: 3 articles (09/2004 - 02/2004)
4.	Kern, Earl R: 3 articles (09/2004 - 02/2004)
5.	Dennis, Phillip A: 2 articles (01/2008 - 04/2004)
6.	Buller, R Mark: 2 articles (01/2008 - 01/2004)
7.	Camacho, Javier: 2 articles (06/2007 - 02/2006)
8.	Mollinedo, Faustino: 2 articles (10/2004 - 10/2002)
9.	Gajate, Consuelo: 2 articles (10/2004 - 10/2002)
10.	Quenelle, Debra C: 2 articles (09/2004 - 02/2004)

Related Diseases

1.	Neoplasms (Cancer) 02/01/2009 - "For investigating the overall lipophilicity of the molecule, the 3-O-hexyl ether group present at position-3 of purpurinimide 5 was replaced with a methyl ether substituent, and the resulting product 10 showed improved tumor uptake, but due to its significantly higher uptake in the liver, spleen, and other organs, a poor tumor contrast in whole-body tumor imaging was observed." 11/25/1994 - "rac-ET-18-OCH3 (1) with its R and S enantiomeric forms, 2 and 3, respectively, exhibited modest stereoselectivity in HUT 78 and Namalwa with 1 and 2 slightly more cytotoxic than 3. Ether lipid (EL) analogs 4, 5, and 6 demonstrated significantly greater cytotoxicity in normal peripheral lymphocytes, 4 and 6 exhibited a modest increase in cytotoxicity in HUT 78 and Namalwa (P < 0.05), and 5 demonstrated greater cytotoxicity (P < 0.05) in Namalwa than the parent EL 1. The calculated 24 h ID50 values suggest that the beta-methyl analogs, 9 and 10, were more cytotoxic than the alpha-methyl analogs, 7 and 8, in all the tested cancer cell lines." 08/01/2008 - "K(+) channels that belong to the human ether-a-go-go-related gene 1 (herg1) family are frequently misexpressed in cancer cells compared to their healthy counterparts. " 07/01/2008 - "Crown ether-peptide construct selectively kills cancer cells." 03/08/2007 - "The present paper demonstrates the antiproliferative ability and structure-activity relationships (SAR) of 14 crown and aza-crown ether analogues on five tumor-cell types. " Order ALL the reference details at left...
2.	Infection 01/01/1981 - "As part of an investigation of intestinal parasitic infections of rural Kenyan people, a study was undertaken to examine variations in faecal egg counts and to assess the sensitivity of the ether sedimentation technique of faecal processing in the diagnosis of helminth infections. " 12/01/2007 - "cruzi and then subjected to repetitive stress by exposure to ether vapor for 1min twice a day during the acute phase of infection. " 02/01/2006 - "Infection with hookworm was determined by microscopic examination of stool samples employing the Kato-Katz technique and an ether-concentration method. " 01/01/2006 - "On day 8 post-infection, the mice were killed by ether, and the small and large intestines collected. " 08/01/2005 - "However, this pathway may become important during infections, when augmented TH breakdown by ether-link cleavage (ELC) may assist in bactericidal activity. " Order ALL the reference details at left...
3.	DNA Damage 10/01/2005 - "[DNA damage induced by methyl tertiary-butyl ether in vivo and in vitro]" 01/01/1996 - "Ether extract from parcel 1 showed an unusually high toxicity for Salmonella typhimurium TA100 and induced DNA damage in Bacillus subtilis with a clear relationship dose-genotoxic response. " 12/01/2006 - "In the present study, endosulfan (as a commercial isomeric mixture and as the alpha- and beta-isomers), and metabolites of endosulfan (the sulfate, lactone, ether, hydroxyether, and diol derivatives) were assayed for their ability to induce DNA damage in Chinese hamster ovary (CHO) cells and human lymphocytes using the Comet assay and were assayed for their mutagenicity using the Salmonella reversion assay (Ames test with TA98, TA97a, TA102, TA104, and TA100, with and without S9 activation). " 04/01/1988 - "To determine the role of the epoxide moiety of the nonprotein chromophore of the antitumor antibiotic neocarzinostatin in its ability to damage DNA, the diol monomethyl ether derivative was prepared, and its stability and biological properties were studied. " 01/01/2002 - "The comet assay showed that acetone extract (100 microg/mL) was more effective in reducing the DNA damage caused by 4-NQO (ca. 90%), whereas the chloroform, ethyl acetate, and diethyl ether extracts were cytotoxic. " Order ALL the reference details at left...
4.	Postherpetic Neuralgia 10/01/1998 - "Topical application of a mixture of acetylsalicylic acid (ASA) and diethyl ether is effective in the treatment of acute herpes zoster and postherpetic neuralgia. " 05/01/1998 - "Skin and plasma levels of acetylsalicylic acid: a comparison between topical aspirin/diethyl ether mixture and oral aspirin in acute herpes zoster and postherpetic neuralgia." 04/01/1997 - "Comments on De Benedittis and Lorenzetti: on topical aspirin/diethyl ether for postherpetic neuralgia, PAIN, 65 (1996) 45-51." 05/01/1998 - "This was done by comparing skin and plasma levels of acetylsalicylic acid (ASA) and salicylic acid (SA) after topically administered ASA/diethyl ether (ADE) mixture in acute herpetic neuralgia (AHN) and postherpetic neuralgia (PHN). " 04/01/1996 - "Topical aspirin/diethyl ether mixture versus indomethacin and diclofenac/diethyl ether mixtures for acute herpetic neuralgia and postherpetic neuralgia: a double-blind crossover placebo-controlled study." Order ALL the reference details at left...
5.	Lymphoma (Lymphomas) 12/11/1995 - "Lymphoma development was completely inhibited by inactivation of cell-free pellets from Si-IIA culture with ethyl ether and was almost suppressed by neutralization of the cell-free pellets with anti-Si-IIA sera. " 09/15/1990 - "Class F Thy-1-negative murine lymphoma cells are deficient in ether lipid biosynthesis." 02/01/1992 - "Differential cytotoxicity of an ether lipid on lymphoma and bone marrow cells and its role in purging malignant lymphoid cells from remission bone marrow contaminated with tumor cells." 09/01/1996 - "Identification of formaldehyde as the metabolite responsible for the mutagenicity of methyl tertiary-butyl ether in the activated mouse lymphoma assay." 09/01/1996 - "Methyl tertiary butyl ether has caused the following cancers in rats and mice: kidney, testicular, liver, lymphomas, and leukemias. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Formaldehyde (Formol)
2.	Acetone
3.	cidofovir (Vistide)
4.	Halothane (Fluothane)
5.	maleic acid (maleate)
6.	Triclosan (pHisoHex)
7.	methoxyethylene-maleic anhydride copolymer
8.	Ethyl Ether (Ether)
9.	Aspirin (Acetylsalicylic Acid)
10.	Silicon Dioxide (Sand)

Related Therapies and Procedures

1.	Anesthesia
2.	Bone Marrow Transplantation (Transplantation, Bone Marrow)
3.	Aftercare (After-Treatment)
4.	Autologous Transplantation (Autograft)
5.	Neuroleptanalgesia

Best Treatments:
Research Summary Report
on Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 20112 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>